Article 05 Jun 2025 Celltrion, Samsung Bioepis, And Organon Receive Interchangeability Designations For Adalimumab Biosimilars United States Healthcare
Article 12 Nov 2024 Daewoong And Celltrion To Market Denosumab Biosimilar In Korea South Korea Healthcare
Article 17 May 2024 Alexion's Preliminary Injunction Motion Denied In Eculizumab BPCIA Litigation Against Samsung Bioepis United States IP
Article 15 Apr 2024 FDA Approves New Indication For AstraZeneca And Daiichi Sankyo's Cancer Drug ENHERTU United States Healthcare
Article 15 Mar 2024 Biocon Settles With Janssen, Securing U.S. Market Entry Date For Ustekinumab Biosimilar United States Healthcare
Article 15 Mar 2024 Biocon Settles With Bayer And Regeneron, Securing Canada Market Entry Date For Aflibercept Biosimilar United States Healthcare